Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Total Liabilities came in at $1.1 billion in Q1 2026, up 27.3% year-on-year from $891.0 million in Q1 2025, and little changed on a QoQ basis from $1.1 billion in Q4 2025.

Lantheus Holdings (LNTH) Total Liabilities (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Total Liabilities data on file, last reported at $1.1 billion in Q1 2026.

  • On a quarterly basis, Total Liabilities rose 27.3% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 27.3% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 27.49% from the prior year.
  • Total Liabilities for Q1 2026 stood at $1.1 billion, roughly flat from $1.1 billion in the prior quarter.
  • Over the last five years, Total Liabilities for LNTH reached as high as $1.2 billion in Q3 2025 and fell as low as $417.3 million in Q1 2022.
  • Historically, Total Liabilities has averaged $845.5 million across 5 years, with a median of $885.8 million in 2024.
  • Across the five-year window, Total Liabilities jumped 118.89% in 2022 and declined 4.44% in 2023, its largest moves.
  • Year by year, Total Liabilities stood at $874.1 million in 2022, then retreated by 4.44% to $835.3 million in 2023, then gained by 6.83% to $892.3 million in 2024, then increased by 27.49% to $1.1 billion in 2025, then declined by 0.29% to $1.1 billion in 2026.
  • Per Business Quant data, the three most recent Total Liabilities figures were $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 1.13 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.13 Bn
Dec 31, 2025 1.14 Bn
Sep 30, 2025 1.16 Bn
Jun 30, 2025 949.29 Mn
Mar 31, 2025 891.03 Mn
Dec 31, 2024 892.33 Mn
Sep 30, 2024 869.92 Mn
Jun 30, 2024 913.15 Mn
Mar 31, 2024 885.79 Mn
Dec 31, 2023 835.26 Mn
Sep 30, 2023 822.85 Mn
Jun 30, 2023 785.08 Mn
Mar 31, 2023 903.77 Mn
Dec 31, 2022 874.11 Mn
Sep 30, 2022 457.89 Mn
Jun 30, 2022 446.49 Mn
Mar 31, 2022 417.32 Mn
Dec 31, 2021 399.35 Mn
Sep 30, 2021 348.47 Mn
Jun 30, 2021 349.66 Mn